Recent Blog Posts

View Post: OHRP, Columbia and Hetastarch: Research Ethics in the News ...
13 Oct 2009 by IUCB  
According to Lenzer and Brownlee, the OHRP's letter to Columbia (June 8, 2009) requires the institution to draft a letter explaining the study and the likelihood that patients who received hetastarch did worse than the others (including ...
View Blog: Indiana Bioethics - http://iucb.wordpress.com/

---

View Post: Government Orders Columbia to Tell Patients 'True Nature' of Drug ...
7 Oct 2009 by The Huffington Post News Team  
Documents later filed in court show that about half of the 215 people who agreed to participate were given hetastarch, and some received up to three times the level recommended by the manufacturers. Some of the subjects were ...
View Blog: Health on The Huffington Post - http://www.huffingtonpost.com/news/health

---

View Post: erchonia: amr finds 75 percent of hetastarch recipients underwent ...
18 Sep 2009 by holly  
erchonia: amr finds 75 percent of hetastarch recipients underwent surgical procedures: arlington medical resources (amr), .. http://bit.ly/4uzqrm. erchonia: amr finds 75 percent of hetastarch recipients underwent surgical procedures: ...
View Blog: Holly Swanson - http://www.hollyswanson.com/

---

View Post: Columbia drug study scandal
16 Oct 2009 by Carolyn Thomas  
Trouble was: two of the study's four blood expanders contained hetastarch, which two previous studies dating back to 1981 had already warned would prevent blood from clotting at high dosages, and one of the two, Hextend, ...
View Blog: The Ethical Nag - http://ethicalnag.org/

---

View Post: significantly higher percentage of hetastarch recipients underwent ...
17 Sep 2009 by amr - Google News  
significantly higher percentage of hetastarch recipients underwent ... reuters amr's new plasma expander hospital inpatient profile study clinically characterizes us hospital inpatient recipients of plasma expanders such as albumin, . ...
View Blog: Google Hot Trend News - http://hottrend.newsm8.com/

---

View Post: Columbia Medical School's 200 Dirty Little Secrets
20 Nov 2009 by admin  
Columbia Medical School administered a drug called hetastarch to open-heart surgery patients. Hetastarch can induce hemorrhaging and resulted in the deaths of two people and harmed over two dozen more. ...
View Blog: The Media Freedom Foundation - http://www.mediafreedominternational.org/

---

View Post: Government Orders Columbia to Tell Patients 'True Nature' of Drug ...
7 Oct 2009 by Erin Drankoski  
According to documents filed by the hospital in New York state court, one purpose of the Columbia trial was to test whether a new formulation of hetastarch, manufactured by Abbott Laboratories, was less likely to trigger serious ...
View Blog: The New America Foundation - - http://www.newamerica.net/

---

View Post: Thursday October 15, 2009 Q: How Hextend is different from regular ...
15 Oct 2009 by ICU room Pearls  
Q: How Hextend is different from regular 6% hetastarch in 0.9% NS? Answer: 6% hetastarch in 0.9% NS contains 154 mEq/L of Sodium and 154 mEq/L of chloride along with 6% hetastarch. Hextand is 6% Hetastarch in Lactated Electrolyte ...
View Blog: icuroom.net October 2009 archive - http://10-09-icuroom.blogspot.com/

---

View Post: The Tangled Web Woven by Industry-Sponsored Research
11 Oct 2009 by Howard Brody  
One ingredient in one of the fluids was hetastarch, which had long been known to trigger serious bleeding. Abbott apparently hoped that a new formulation of hetastarch would minimize the bleeding risks. However, the consent form ...
View Blog: Hooked: Ethics, Medicine, and Pharma - http://brodyhooked.blogspot.com/

---